---
title: "Executive Summary: Justice-Involved Populations"
date: 2026-06-24
author: "Syam Adusumilli"
summary: "Executive summary of Justice-Involved Populations"
tags: ["rural-health", "rhtp", "health-equity", "series-9", "summary"]
showtoc: false
ShowReadingTime: true
ShowBreadCrumbs: true
params:
  is_summary: true
  full_article_url: "../justice-involved-populations/"
  article_id: "RHTP-9L-Summary"
  collection: "rural-health"
weight: 999
cover:
  image: "cover.webp"
  alt: "Cover image"
  relative: true
build:
  list: never
---

The Rural Health Transformation Program confronts a population whose healthcare needs are extreme but whose political visibility approximates zero. More than 650,000 people return to communities from state and federal prisons annually, while roughly 10 million jail admissions cycle individuals through facilities and back to communities within weeks or months. These transitions create healthcare discontinuities that compound already-elevated health needs: chronic conditions undertreated during incarceration, mental illness unmanaged, substance use disorders unaddressed, medications expiring within days of release. The population returning from incarceration carries health burdens that dwarf general population rates. Mental health conditions affect 44% compared to 19% in the general population, serious mental illness affects 14 to 24% compared to 5%, and substance use disorder histories characterize 65% or more compared to 8%. Hepatitis C prevalence reaches 17% versus 1% in the general population, a sixteen-percentage-point gap reflecting both pre-incarceration risk factors and transmission during incarceration itself.

The analytical tension this population illuminates is **population visibility versus population need**. Justice-involved individuals have among the highest healthcare needs of any group while possessing among the lowest political visibility and support. They cannot vote in many states. Political systems do not reward investment in people society has designated for punishment. The electoral calculation is straightforward: justice-involved health investment generates no political return and risks accusations of coddling criminals. RHTP's promise to transform rural health for all rural residents tests whether transformation can reach populations that politics renders invisible and morality debates render controversial.

Rural communities experience justice involvement distinctly from urban areas. Approximately 200,000 or more individuals are held in rural county jails at any given time, facilities that often operate with minimal healthcare capacity. A rural jail might have a nurse available eight hours daily with physician visits weekly or less frequently. Psychiatric services may require transport to distant facilities. Medication continuity depends on systems that rural jails frequently lack capacity to maintain. The rural dimension compounds both during incarceration (fewer health resources in smaller facilities) and upon release (returning to communities with minimal healthcare infrastructure, transportation barriers to distant services, behavioral health treatment deserts, limited housing options, fewer employment opportunities, weaker social service networks).

The constitutional floor for carceral healthcare does not equal adequate care. The 1976 Supreme Court decision Estelle v. Gamble established that the Eighth Amendment prohibits deliberate indifference to serious medical needs of incarcerated people, creating one of the few contexts in America where healthcare is legally guaranteed regardless of ability to pay. However, constitutional requirements mandate only that facilities not be deliberately indifferent, a standard that permits long waits, gatekeeping, care delays, and quality that would be considered inadequate in community settings. Medication-assisted treatment for opioid use disorder remains unavailable in most facilities despite expanding legal challenges and policy changes. Roughly 70% of state prisons offer some form of MAT, but only 30% provide full access to all three FDA-approved medications (methadone, buprenorphine, naltrexone). Local jails lag further behind, with approximately 30% offering any MAT and only 15% providing full access. Most facilities that offer MAT provide only naltrexone, often injectable Vivitrol, which does not require DEA licensing and cannot be diverted. Buprenorphine and methadone, often more effective for many patients, remain less available due to regulatory barriers, diversion concerns, and ideological opposition to medication-based treatment.

For people stable on MAT prior to incarceration, forced withdrawal upon entry creates immediate crisis. For people who could benefit from MAT initiation during incarceration, absence of services means untreated addiction. For both groups, release without MAT continuity produces overdose risk that manifests in the weeks following release. Research documents dramatically elevated mortality risk in this period: the first one to two weeks post-release carry 12.7 times baseline mortality risk, driven primarily by overdose, homicide, and suicide. The first month carries 3.5 times baseline risk, with overdose and cardiovascular events predominating. The entire first year post-release carries twice baseline mortality risk across all causes. **Opioid overdose drives much of the immediate post-release mortality** because tolerance to opioids decreases during incarceration, whether through forced abstinence or MAT. Upon release, individuals who resume opioid use at pre-incarceration levels face extreme overdose risk because their bodies no longer tolerate previous doses.

The federal Inmate Payment Exclusion prohibits Medicaid from paying for services provided during incarceration except inpatient hospitalization exceeding 24 hours. This policy does not make incarcerated individuals ineligible for Medicaid but prevents federal payment during incarceration. States historically responded by terminating Medicaid enrollment at incarceration, requiring released individuals to reapply from scratch. Beginning January 1, 2026, the Consolidated Appropriations Act of 2024 requires all states to suspend rather than terminate Medicaid coverage, representing significant progress that nonetheless does not eliminate coverage gaps. Even with suspension, **bureaucratic delays, system disconnects, and administrative barriers produce coverage lapses**. Studies find that even in suspension states, released individuals frequently experience days to weeks without active coverage while reinstatement processes complete.

CMS has encouraged states to pursue Section 1115 demonstration waivers enabling Medicaid coverage for pre-release services. As of August 2024, eleven states have received approval including California, Illinois, Kentucky, Massachusetts, Montana, Oregon, Utah, Vermont, and Washington. These demonstrations allow limited Medicaid payment for services in the 90 days prior to release, including physical and behavioral health screening, treatment for chronic conditions, care coordination and discharge planning, connection to community providers, and medication bridging. California will be the first state to implement its reentry demonstration in October 2024, potentially informing other states' approaches. However, rural jails often lack capacity to participate in these demonstrations. The administrative requirements, data sharing systems, and provider networks required for effective pre-release services exceed what many rural counties can implement without significant technical assistance.

The case of Marcus, a 34-year-old man released from Greene County Jail after six months, illustrates how system gaps compound into crisis. Marcus has type 2 diabetes, major depression, and opioid use disorder. Before arrest, he managed diabetes with metformin and depression with sertraline obtained through a community health center sliding-fee program. The jail's contracted nurse continues his metformin and sertraline but cannot initiate MAT because the jail has no MAT program. Marcus experiences opioid withdrawal managed with comfort medications but no treatment for the underlying disorder. Upon release, Marcus receives a two-week supply of metformin but no prescription he can refill. His sertraline runs out because the jail did not provide any. His Medicaid, suspended during incarceration, shows as inactive when he attempts to use it at a pharmacy three days post-release. Greene County has no behavioral health provider. The community health center where Marcus previously received care has a six-week wait for returning patients. The nearest MAT provider is 45 miles away and not accepting new patients. Marcus has no vehicle and public transportation does not exist in Greene County. Within the first week, his diabetes medication supply dwindles. Two weeks post-release, Marcus experiences a diabetic crisis requiring emergency transport to a hospital 30 miles away. He is stabilized and discharged with prescriptions but no means to fill them and no follow-up care arranged. At week three, Marcus relapses. His tolerance has decreased during six months of forced abstinence. The dose that would have produced euphoria before incarceration produces respiratory depression now. A friend finds him unresponsive and calls 911. The rural EMS response time is 22 minutes. Marcus survives with permanent anoxic brain injury.

State RHTP applications vary dramatically in their recognition of justice-involved populations. California's approach integrates justice-involved populations into Enhanced Care Management under CalAIM, identifying people transitioning from incarceration as a priority population requiring intensive care coordination. Kentucky has pursued Section 1115 reentry demonstration approval and operates programs connecting incarcerated individuals to community services before release. Massachusetts and North Carolina mention reentry coordination and prison Medicaid enrollment in their applications. Texas provides minimal attention beyond general rural focus. Mississippi and Alabama include no justice-involved provisions. Most states treat "rural residents" as a homogeneous category without distinguishing populations with distinct healthcare transition needs. Justice-involved individuals are rural residents, but their healthcare needs during reentry differ from needs of settled community members with continuous coverage and established provider relationships.

RHTP's flexible structure could support reentry health if states chose this priority. RHTP funding could support pre-release care coordination programs in rural jails, Medicaid enrollment assistance during incarceration, MAT expansion in rural carceral facilities, reentry health navigation services, telehealth connecting rural released individuals to behavioral health providers, and community health worker programs targeting reentry populations. RHTP funding could support **rural jail health capacity building** that current criminal justice funding streams cannot